Related Articles
Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer
No association between triple‑negative breast cancer and prognosis of patients receiving breast‑conserving treatment
Elevated tumor mutation burden and immunogenic activity in patients with hormone receptor‑negative or human epidermal growth factor receptor 2‑positive breast cancer
Strong impact of pathological node‑negative on long‑term overall survival of patients with triple‑negative breast cancer receiving neoadjuvant chemotherapy
Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer